RKDA - Arcadia Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate-1.13-1.06-8.28-3
Low Estimate-1.13-1.06-8.28-3
High Estimate-1.13-1.06-8.28-3
Year Ago EPS-2-1.8N/A-8.28
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate260k220k1.13M1.4M
Low Estimate260k220k1.13M1.4M
High Estimate260k220k1.13M1.4M
Year Ago Sales589k1.43M4.03M1.13M
Sales Growth (year/est)-55.90%-84.60%-71.90%23.90%
Earnings History3/30/20176/29/20179/29/20176/29/2018
EPS Est.-1.4-2.2-1.6-1.29
EPS Actual-2-1.8-2.2-2.02
Difference-0.60.4-0.6-0.73
Surprise %-42.90%18.20%-37.50%-56.60%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate-1.13-1.06-8.28-3
7 Days Ago-1.13-1.06-8.28-3
30 Days Ago-1.13-1.06-8.28-3
60 Days Ago-1.09-1.03-5.01-3
90 Days Ago-0.74-0.71-3.81-2.16
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRKDAIndustrySectorS&P 500
Current Qtr.43.50%N/AN/A0.32
Next Qtr.41.10%N/AN/A0.43
Current YearN/AN/AN/A0.24
Next Year63.80%N/AN/A0.27
Next 5 Years (per annum)14.96%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A